Frank Speleman

6.1k citations

23 papers · 4.8k indexed · 1 hit paper · h-index 18

Molecular Biology top 2%
Plant Science top 2%
Cancer Research top 2%
Genetics top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Jo Vandesompele Geert Mortier Anne De Paepe Jan Hellemans Jessica Zucman‐Rossi Göran Stenman Alan L. Epstein Olivier Delattre
Topics: RNA modifications and cancer (5 papers)Neuroblastoma Research and Treatments (4 papers)Genomic variations and chromosomal abnormalities (4 papers)
Cited by: Cancer Research Molecular Biology Neurology
Journals: Nucleic Acids Research Nature Genetics Molecular Cell
Partner nations: Belgium Germany United States

In The Last Decade

Frank Speleman

23 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

2007 3.4k citations Jan Hellemans, Geert Mortier et al. Genome biology profile →

Peers

Countries citing papers authored by Frank Speleman

Since Specialization

Citations

This map shows the geographic impact of Frank Speleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Speleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Speleman more than expected).

Fields of papers citing papers by Frank Speleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Speleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Speleman. The network helps show where Frank Speleman may publish in the future.

Co-authorship network of co-authors of Frank Speleman

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Speleman. A scholar is included among the top collaborators of Frank Speleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Speleman. Frank Speleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Network Modeling of microRNA–mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN 2018 ·Cancer Research ·(unknown),Daniel R. Carter,Bing Liu,Chelsea Mayoh,Anneleen Beckers,(unknown),Zsuzsanna Nagy,Sara De Brouwer,Bieke Decaesteker,Tzong‐Tyng Hung,Murray D. Norris,Michelle Haber,Tao Liu,Katleen De Preter,Frank Speleman,Belamy B. Cheung,Glenn M. Marshall	45
2	Glutathione biosynthesis is upregulated at the initiation of MYCN‐driven neuroblastoma tumorigenesis 2016 ·Molecular Oncology ·Daniel R. Carter,Selina K. Sutton,Marina Pajic,Jayne Murray,Eric Sekyere,Jamie I. Fletcher,Anneleen Beckers,Katleen De Preter,Frank Speleman,Rani E. George,Michelle Haber,Murray D. Norris,Belamy B. Cheung,Glenn M. Marshall	20
3	A nanobody modulates the p53 transcriptional program without perturbing its functional architecture 2014 ·Nucleic Acids Research ·(unknown),(unknown),Olivier Zwaenepoel,Abel Garcia‐Pino,Kaat Durinck,(unknown),Gholamreza Hassanzadeh‐Ghassabeh,Frank Speleman,Remy Loris,Jan Gettemans	31
4	Effective Alu Repeat Based RT-Qpcr Normalization in Cancer Cell Perturbation Experiments 2013 ·PLoS ONE ·Ali Rihani,Tom Van Maerken,Filip Pattyn,Gert Van Peer,Anneleen Beckers,Sara De Brouwer,Candy Kumps,Evelien Mets,Joni Van der Meulen,Pieter Rondou,Carina Leonelli,Pieter Mestdagh,Frank Speleman,Jo Vandesompele	12
5	CLL Cells Respond to B-Cell Receptor Stimulation with a MicroRNA/mRNA Signature Associated with MYC Activation and Cell Cycle Progression 2013 ·PLoS ONE ·(unknown),(unknown),Jolien Vermeíre,Evelien Naessens,Pieter Mestdagh,(unknown),Hanne Vanderstraeten,Nadine Van Roy,Jo Vandesompele,Frank Speleman,Jan Philippé,Bruno Verhasselt	30
6	Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q− Neuroblastoma 2010 ·Clinical Cancer Research ·Patrick G. Buckley,Leah Alcock,Kenneth Bryan,Isabella Bray,Johannes H. Schulte,Alexander Schramm,Angelika Eggert,Pieter Mestdagh,Katleen De Preter,Jo Vandesompele,Frank Speleman,Raymond L. Stallings	54
7	The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma 2010 ·Molecular Cell ·Pieter Mestdagh,(unknown),Francis Impens,Erik Fredlund,Gert Van Peer,Pasqualino De Antonellis,Kristoffer von Stedingk,Bart Ghesquière,Stefanie Schulte,Michael Dews,Andrei Thomas‐Tikhonenko,Johannes H. Schulte,Massimo Zollo,Alexander Schramm,Kris Gevaert,Håkan Axelson,Frank Speleman,Jo Vandesompele	252
8	Challenges for CNV interpretation in clinical molecular karyotyping: Lessons learned from a 1001 sample experience 2009 ·European Journal of Medical Genetics ·Karen Buysse,Barbara Delle Chiaie,Rudy Van Coster,Bart Loeys,Anne De Paepe,Geert Mortier,Frank Speleman,Björn Menten	81
9	qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR databreakdown → 2007 ·Genome biology ·Jan Hellemans,Geert Mortier,Anne De Paepe,Frank Speleman,Jo Vandesompele	3373
10	ComprehensiveNF1 screening on cultured Schwann cells from neurofibromas 2006 ·Human Mutation ·Ophélia Maertens,Hilde Brems,Jo Vandesompele,Thomas De Raedt,(unknown),Thorsten Rosenbaum,Sofie De Schepper,Anne De Paepe,Geert Mortier,Sandra Janssens,Frank Speleman,Eric Legius,Ludwine Messiaen	82
11	Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons 2004 ·BMC Genomics ·Katleen De Preter,Filip Pattyn,Geert Berx,Kristin Strumane,Björn Menten,Frans van Roy,Anne De Paepe,Frank Speleman,Jo Vandesompele	24
12	Molecular cytogenetic analysis of complex chromosomal rearrangements in patients with mental retardation and congenital malformations: Delineation of 7q21.11 breakpoints 2003 ·American Journal of Medical Genetics Part A ·Stefan Vermeulen,Björn Menten,Nadine Van Roy,Heidi Van Limbergen,Anne De Paepe,Geert Mortier,Frank Speleman	17
13	Elimination of Primer–Dimer Artifacts and Genomic Coamplification Using a Two-Step SYBR Green I Real-Time RT-PCR 2002 ·Analytical Biochemistry ·Jo Vandesompele,Anne De Paepe,Frank Speleman	189
14	Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects 2000 ·Human Mutation ·Ludwine Messiaen,Tom Callens,Geert Mortier,Diane Beysen,Ina Vandenbroucke,Nadine Van Roy,Frank Speleman,Anne De Paepe	31
15	Noonan-like phenotype in monozygotic twins with a duplication-deficiency of the long arm of chromosome 18 resulting from a maternal paracentric inversion 1998 ·Human Genetics ·Winnie Courtens,(unknown),(unknown),Ludwine Messiaen,Esther Vamos,(unknown),Dominique Haumont,(unknown),Anna Jauch,Joris Vermeesch,Frank Speleman	32
16	Monosomy 22 in a mixed germ cell-sex cord-stromal tumor of the ovary 1997 ·Genes Chromosomes and Cancer ·Frank Speleman,Bart Dermaut,Christian R. De Potter,Mireille Van Gele,Nadine Van Roy,(unknown),Geneviève Laureys	12
17	Molecular cytogenetic analysis of a familial pericentric inversion of chromosome 12 1993 ·Clinical Genetics ·Frank Speleman,Nadine Van Roy,(unknown),Carl Hilliker,R.F. Suijkerbuijk,(unknown)	12
18	EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts 1993 ·Nature Genetics ·Jessica Zucman‐Rossi,Olivier Delattre,Chantal Desmaze,Alan L. Epstein,Göran Stenman,Frank Speleman,(unknown),Alain Aurias,Anthony J. Gill	395
19	Is t(6;20)(p21;q13) a characteristic chromosome change in endometrial polyps? 1991 ·Genes Chromosomes and Cancer ·Frank Speleman,Paola Dal Cin,Nadine Van Roy,E. Van Marck,(unknown),(unknown),Jules G. Leroy	16
20	Cytogenetic analysis of a mesenchymal hamartoma of the liver 1989 ·Cancer Genetics and Cytogenetics ·Frank Speleman,(unknown),Kathleen A. Potter,Paola Dal Cin,Sabine Van daele,Yves Benoît,Jules G. Leroy,(unknown)	51

About Frank Speleman

Frank Speleman is a scholar working on Neurology, Cancer Research and Genetics, having authored 23 papers that have together received 4.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Neuroblastoma Research and Treatments (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Cancer Research (691 citations), Molecular Biology (2.6k citations) and Neurology (355 citations). Frank Speleman has collaborated with scholars based in Belgium, Germany and United States. Frequent co-authors include Jo Vandesompele, Geert Mortier, Anne De Paepe, Jan Hellemans, Anne De Paepe, Jessica Zucman‐Rossi, Göran Stenman, Alan L. Epstein, Olivier Delattre and Chantal Desmaze. Their work appears in journals such as Nucleic Acids Research, Nature Genetics and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact